Systematic Investigation of DNA Methylation Associated With Platinum Chemotherapy Resistance Across 13 Cancer Types
Background: Platinum resistance poses a significant problem for oncology clinicians. As a result, the role of epigenetics and DNA methylation in platinum-based chemoresistance has gained increasing attention from researchers in recent years. A systematic investigation of aberrant methylation pattern...
Main Authors: | Ruizheng Sun, Chao Du, Jiaxin Li, Yanhong Zhou, Wei Xiong, Juanjuan Xiang, Jiheng Liu, Zhigang Xiao, Li Fang, Zheng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.616529/full |
Similar Items
-
Promoter Methylation of the MGRN1 Gene Predicts Prognosis and Response to Chemotherapy of High-Grade Serous Ovarian Cancer Patients
by: Xiao-fei Li, et al.
Published: (2021-06-01) -
Efficacy and safety of irinotecan/platinum versus etoposide/platinum chemotherapy for extensive-stage small cell lung cancer
by: LI Nengsheng, et al.
Published: (2019-01-01) -
Pharmacogenomics for the efficacy of platinum-based chemotherapy: Old drugs, new integrated perspective
by: Chen-Xue Mao, et al.
Published: (2020-06-01) -
A meta-analysis of Pemetrexed plus Platinum Chemotherapy versus Gemcitabine plus Platinum Chemotherapy for Advanced Non-small Cell Lung Cancer
by: Jin JIANG, et al.
Published: (2011-01-01) -
Effects of thermal-neutron irradiation on platinum and dilute platinum-gold alloys
by: Piani, Charles Sante Bernardo
Published: (2015)